JPAM_logo
  • Funds

    Fund Listing

    • Fund Explorer
    • Fund Managers
    • Fund Documents

    Featured Funds

    • Multi Income Fund
    • Asian Total Return Bond Fund
    • China Bond Opportunities Fund
    • Income Fund
  • Insights

    Market Insights

    • Market Insights Overview
    • Guide to the Markets
    • Weekly Market Recap
    • On the Minds of Investors
    • Multimedia

    Portfolio Insights

    • Portfolio Insights Overview
    • Long-Term Capital Market Assumptions
    • Global Asset Allocation Views
    • Global Fixed Income Views

    Retirement Insights

    • Retirement Insights Overview
    • Principles for a Successful Retirement
    • Building Better Retirement Portfolios
    • Are you letting volatility derail your retirement plan?
  • Investment Ideas
    • Managing Volatility
    • Growth Strategy
    • Income Strategy
    • Retirement and long-term investing
  • Resources
    • Announcements
    • Forms & Literature
    • Investment Glossary
    • Library
  • About Us
    • Awards
  • Partner With Us
Skip to main content
  • Language
    • English
    • 中文/ Chinese
  • Role
  • Country
Search
Menu
CLOSE
Search
  1. Home
  2. Insights
  3. Market Insights
  4. On the Minds of Investors
  5. What should investors do, given the latest surge in COVID-19 in Europe and the U.S.?

  • Share
  • LinkedIn Twitter Facebook Line
  • Print
  • Actions
  • LinkedIn Twitter Facebook Line
    Print

On the Minds of Investors

27/10/2020

Tai Hui

What should investors do, given the latest surge in COVID-19 in Europe and the U.S.?

Europe and the U.S. are going through another wave of COVID-19 pandemic outbreak. In Europe, many countries are facing record high infection numbers beyond the first wave in March/April. Momentum is particularly strong in Italy, France, Belgium, Czech Republic and Switzerland. In the U.S., the daily infection number has exceeded the peak in the summer. As a result, many governments are reintroducing social distancing and lockdown measures to control the spread of the virus. This has triggered concerns that these economies could dip back into recession.

While the infection numbers are hitting record highs in many of these countries, there are several encouraging signs. First, the percentage of COVID-19 tests that returned with a positive result has risen, but still below the peak in March/April. This indicates that the higher number of new infections is partly due to more tests available. Second, hospital admissions are also lower than the previous peak. Healthcare systems are better at screening those that need hospital treatments, versus patients with milder symptoms. Third, the mortality rate is also lower. Lower hospitalization and mortality rates are due to the infected group of patients being younger than the previous wave, but that trend is slowly changing with the older population’s infection rate also creeping higher. 

Not only are healthcare services more experienced at directing resources to those patients with the greatest needs, governments are also taking a more selective approach in their lockdown policies. Instead of a nationwide lockdown, most governments are trying to limit movement in cities or areas with the highest infection rates in order to reduce the economic costs.

As the pandemic is becoming more like a marathon, rather than a sprint, governments will need to be strategic in how they distribute fiscal resources to businesses and families. Regardless of policymakers’ strategies, more fiscal stimulus will be needed before the end of the year as Europe and the U.S. try to prevent their economies from falling back into contraction. In the U.S., it seems increasingly likely that this would come after the elections on November 3.

A weaker growth environment should not come as a complete surprise to markets, which have been expecting a sharp surge in quarter-over-quarter growth in 3Q 2020 for the U.S. and Europe, and returning to a more muted expansion in 4Q 2020 and 1Q 2021. One important question would be how this deceleration in recovery momentum would impact corporate earnings. 3Q corporate earnings in the U.S. and Europe have been encouraging, which might compensate for some softness in 4Q. 

EXHIBIT 1: MONITORING EUROPE AND THE U.S.

Source: J.P. Morgan Asset Management; (Left) European Center for Disease Control, U.S. Department of Health and Human Services; (Right) Johns Hopkins CSSE, The World Bank. Data reflect most recently available as of 20/10/20.

Investment implications

The pandemic continues to be the most important factor influencing the global economy and investment landscape in the next 12 months. The latest setback with regards to the pandemic in the U.S. and Europe is not a complete surprise as many medical experts have already warned that another spike would come when winter arrives in the Northern hemisphere. Nonetheless, the latest surge should push investors to take a more defensive position for the time being. In the very short term, the U.S. elections would reinforce this conservative bias.

This would imply room for more consolidation in global equities. While U.S. corporate debt, especially high yield and emerging market debt, have a positive correlation with equities, their high-income attribute continues to benefit from ultra loose monetary policy from developed market central banks. A loss of momentum in recovery simply strengthens policymakers’ case to keep stimulus coming.

In the longer term, the U.S. election results, regardless of the outcome, should provide the certainty that investors are constantly looking for. Meanwhile, as the outbreak becomes more contained due to social distancing measures, this should also restore investor confidence. We still believe that a sustained medical solution, whether a breakthrough in vaccine research, or a more efficient and cheap testing process, will help to facilitate the next stage of economic recovery, which would be constructive for global equities, especially those sectors which have been the worst hit by the pandemic.

In sum, we think investors should focus more on U.S. high yield and emerging market debt in the near term, while looking for opportunities to add to a diversified portfolio of equities in anticipation of a more comprehensive global recovery in 2021. 

0903c02a82a45edb

FEATURED FUNDS

Asian Total Return Bond Fund

READ MORE
J.P. Morgan Asset Management

  • Terms of Use
  • Privacy Statement
  • Cookies Policy
  • Investment Stewardship
  • Fund Notes
  • Offering Document(s)
  • Forms & Literature
  • Guide to Using This Website
  • Sitemap
J.P. Morgan

  • J.P. Morgan
  • JPMorgan Chase
  • Chase

Important: This area of the website is intended only for distributors of JPMorgan Funds (Asia) Limited. Information is not intended for retail or public distribution.

Investment involves risk. Past performance is not indicative of future performance. In particular, funds which are invested in emerging markets and smaller companies may involve a higher degree of risk and are usually more sensitive to price movements. Investors should carefully read and consider the fund offering document(s), which contain details on investment objectives, risk factors, charges and expenses of the fund, before making any investment decisions. Information in this website does not constitute investment advice, or an offer to sell, or a solicitation of an offer to buy any security, investment product or service, nor a distribution of information for any such purpose. Informational sources are considered reliable but you should conduct your own verification of information contained herein. The above information has not been reviewed by the SFC, issued by JPMorgan Funds (Asia) Limited.

Copyright 2021 JPMorgan Funds (Asia) Limited. All rights reserved.